findmyKOL
Clinical trialNCT01711515CompletedPhase 1Interventional

Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

SponsorNational Cancer Institute (NCI)Enrollment34Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB2 Cervical Cancer AJCC v6 and v7Stage II Cervical Cancer AJCC v7Stage IIA Cervical Cancer AJCC v7+3 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Los Angeles County-Usc Medical Center

    Los Angeles, California, United States

  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Uc Irvine Health/chao Family Comprehensive Cancer Center

    Orange, California, United States

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, United States

  • Hartford Hospital

    Hartford, Connecticut, United States

  • the Hospital of Central Connecticut

    New Britain, Connecticut, United States

  • Augusta University Medical Center

    Augusta, Georgia, United States

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico, United States

  • Montefiore Medical Center-Einstein Campus

    The Bronx, New York, United States

  • Case Western Reserve University

    Cleveland, Ohio, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania, United States

  • Women and Infants Hospital

    Providence, Rhode Island, United States

  • Virginia Commonwealth University/massey Cancer Center

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Oct 2012
Primary completion
9 Feb 2017
Completion
17 Jul 2020
Last update posted
2 Sept 2020
Registered enrollment
34
Registry id
NCT01711515

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.